FDA Warns Against Use of Hyperbaric Oxygen Treatments
September 16, 2013
A new wave of alternative treatments is available to patients looking to cure health conditions. However, many of these new treatments have not undergone extensive testing, nor have they been proven to be effective. The Colorado Defective Product Lawyers with McDivitt Law Firm say this could potentially lead to serious injuries.
One such treatment that has come under scrutiny by the U.S. Food and Drug Administration (FDA) is something called hyperbaric oxygen treatment (HBOT). The treatment works by placing the patient in a chamber where air pressure is altered, allowing the patient’s body to absorb larger amounts of oxygen than normal. Usually, these treatments are used on divers who have ascended too quickly; however, the chamber are now being used to treat conditions such as:
- Brain injury
- Spinal cord injury
- Parkinson’s disease
The FDA has stated that HBOT has not received approval as a treatment for these conditions. Furthermore, patients undergoing HBOT may suffer serious adverse health events that can include joint pain, paralysis, embolism, burns, or even death. So far, the FDA has received 27 complaints regarding HBOT treatments.
McDivitt Law Firm’s team of Colorado Personal Injury Lawyers is here to help anyone who has been harmed by a treatment performed by a doctor that was not approved as a remedy for their condition.Back to the Blog